Maxbruins (@maxbruins) profile picture

Maxbruins

@maxbruins

MD, PhD, Urologist| uro-oncology | EAU MIBC Guideline member

Joined October 2018
  • Tweets63
  • Following70
  • Followers60
2Media
Photo by Maxbruins (@maxbruins)Photo by Maxbruins (@maxbruins)
Great trick.
Alexander Kutikov MD (@uretericbud) profile pictureAlexander Kutikov MD
@uretericbud21 Dec 2021
Air bubble impeding resection during TURBT? 😡 Here’s a superb trick that doesn’t get used enough out there. Tnx @LauraBukavinaMD for pushing to make video. (I believe I learned this from @UroCorrea a few years back!) #urotipsandtricks
Air bubble impeding resection during TURBT? 😡 Here’s a superb trick that doesn’t get used enough out there. Tnx @LauraBukavinaMD for pushing to make video. (I believe I learned this from @UroCorrea a few years back!) #urotipsandtricks
29
90
17
354
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma buff.ly/3o4MSKX @Uroweb @Els_Urology #eauguidelines @MattMilowsky @MariaJRibal
Image from European Urology (@EUplatinum)
2
92
4
165
Happy to see our MMI #bladdercancer #eauguidelines PANEL meet again in-person to finalise 2022 update.!!! @A_Carrion_Puig @MichaelRink_MD @evacomperat @MattMilowsky @maxbruins @Yann_Neuzillet @VPanebiancoIT
Image from Maria J. Ribal (@MariaJRibal)
1
5
2
47
pubmed.ncbi.nlm.nih.gov/3444… @JUrology
Image from Prof Nikhil Vasdev (@nikhilvasdevuro)
14
1
35
#hugodejonge 8mnd geleden mijn voorspelling: helaas uitgekomen. Een fortuin aan belastinggeld weggeflikkerd aan een loze belofte van “300-400M #AstraZeneca vaccins”. Een domme en overhaaste beslissing, dat geld zien we niet meer terug.
Image from Maxbruins (@maxbruins)
2
Muscle-invasive #bladdercancer #eauguidelines panel virtual meeting: updating for 2021: imaging, pathology, neoadjuvant and adjuvant, surgery: pay attention to new release next year.!
Image from Maria J. Ribal (@MariaJRibal)
1
5
55
Replying to @EUplatinum @F_Montorsi @BandiniMd @prokarurol @KhurshidGuru @HitenDPatel
I agree with EAU MIBC Guidelines statement that ORC is the “current best practice” and RARC is “feasible but still investigational” since that is the reality in global real-life scenarios. @SWilliams_MD @siadaneshmand @bbmdmsk @garysteinbergmd @MRoupret
9
25
“Demonstratie te belangrijk om in te grijpen”... #FemkeHalsema ga je kapotschamen
Image from Maxbruins (@maxbruins)
3
8
This month’s @EurUrolOncol #SoMe Award is presented to… The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for #BladderCancer A Systematic Review by @uroweb #eauguidelines euoncology.europeanurology.c…
Image from European Urology Oncology (@EurUrolOncol)
Image from European Urology Oncology (@EurUrolOncol)
2
19
41
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines @Uroweb @MariaJRibal europeanurology.com/article/…
Image from European Urology (@EUplatinum)
2
38
75
Hospital volume as significant predictor of perioperative outcomes after #radicalcystectomy: the importance of centralization on complex surgical care. Read more 👇 bladder.uroonco.uroweb.org/p… #bladdercancer #eauguidelines @MariaJRibal @evacomperat @frasor86 @EUplatinum
12
1
14
Prognostic and toherapeutic influence of variant histology in #bladdercancer: data are still immature! Read more👇 bladder.uroonco.uroweb.org/p… #GUcancers #oncourology #eauguidelines @rsybru @UroDocAsh @UroMoschini @EUplatinum @EurUrolOncol @UrowebESU
8
11
buff.ly/2tHsx6v Hospital and Surgeon Volume as Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
1
12
24
Adjuvant atezolizumab not reaching its disease free survival endpoint in bladder cancer is a surprise . Preliminary data suggested early treatment should help patients. We will need reassess what we think we know. roche.com/media/releases/med…
6
27
6
60
Replying to @UroDocAsh @EUplatinum
Important study and supplements our findings except further understanding hospital and surgeon factors beyond volume critical to improve outcomes and RC use. @JimCatto sciencedirect.com/science/ar… – at Friendswood, TX
1
5
Outcomes after cystectomy for #BladderCancer linked to volume Recommended threshold per hospital (not surgeon!) ~ 20 per year In US, 12.7% of RCs performed in hospitals with <3 RCs annually; 23.1% performing 4-10 RCs, 26.6% of RCs in hospitals with >50 annually @EUplatinum
Rafael Sanchez-Salas (@RSanchez_Salas) profile pictureRafael Sanchez-Salas@RSanchez_Salas11 Jan 2020
More than 20 cases per year is the ideal for Radical Cystectomy volume. Improved outcomes! euoncology.europeanurology.c…
4
15
48
More than 20 cases per year is the ideal for Radical Cystectomy volume. Improved outcomes! euoncology.europeanurology.c…
1
9
2
22
#eauguidelines panel on Muscle-invasive #bladdercancer recommends hospitals to perform at least 10, and preferably >20, RCs annually or refer the patient to a center that reaches this number euoncology.europeanurology.c…
3
47
4
96
Hospitals should at least perform 10 RCs for bladder cancer per year. el.elsevierhealth.com/wf/cli…
2
8
13
Load more